
Bioorganic and Medicinal Chemistry Letters p. 759 - 764 (1999)
Update date:2022-09-26
Topics:
Takeuchi, Kumiko
Kohn, Todd J.
Sall, Daniel J.
Denney, Michael L.
McCowan, Jefferson R.
Smith, Gerry F.
Gifford-Moore, Donetta S.
A novel series of benzo[b]thiophene diamine thrombin inhibitors with a conformationally restricted C3-side chain 3 was investigated. The constrained C3-side chain by a cyclohexyl ring contributed to not only an additive but also a synergistic effect on the thrombin inhibitory activity. The SAR studies resulted in the discovery of a potent thrombin inhibitor 27 that was over 750-fold more potent than the initial lead compound 1.
View MoreSuzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
Shanggao Ruiya Fine Chemicals Co., Ltd
Contact:+86-795-2592103
Address:Xingguang Nanlu,Shanggao County Industry Park
Antaeus Bio-technology Co., LTD(expird)
Contact:021-31252569
Address:shanghai pudong
Jinan Trio PharmaTech Co., Ltd
Contact:86-531-88811783;+(0)13153010282
Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
WUHU HUAHAI BIOLOGY ENGINEERING CO LTD
Contact:+86-553-3836920
Address:7/F NO.82 LAODONG ROAD WUHU CHINA
Doi:10.1016/S0020-1693(00)87947-5
(1985)Doi:10.1016/S0040-4039(01)81831-1
(1981)Doi:10.1021/jo01112a608
(1956)Doi:10.1021/jo01037a021
(1963)Doi:10.1016/j.tetasy.2013.12.002
(2014)Doi:10.1039/jr9610000872
(1961)